Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis

Reported prevalence estimates of sporadic cerebral amyloid angiopathy (CAA) vary widely. CAA is associated with cognitive dysfunction and intracerebral hemorrhage, and linked to immunotherapy‐related side‐effects in Alzheimer's disease (AD). Given ongoing efforts to develop AD immunotherapy, ac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alzheimer's & dementia 2022-01, Vol.18 (1), p.10-28
Hauptverfasser:	Jäkel, Lieke, De Kort, Anna M., Klijn, Catharina J.M., Schreuder, Floris H.B.M., Verbeek, Marcel M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - drug therapy Alzheimer's disease amyloid Boston criteria cerebral amyloid angiopathy Cerebral Amyloid Angiopathy - epidemiology Cerebral Amyloid Angiopathy - pathology Cerebral Hemorrhage - epidemiology Cognitive Dysfunction - drug therapy Humans immunotherapy Immunotherapy - adverse effects intracerebral hemorrhage Magnetic Resonance Imaging - standards meta‐analysis microbleeds MRI Neuropathology Prevalence systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!